医薬品製造委託の世界市場2016-2026...市場調査レポートについてご紹介

【英文タイトル】Pharmaceutical Contract Manufacturing Market 2016-2026 : Discover Revenue Forecasts for Active Ingredient (API) and Finished Dose Formulation (FDF) Services

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Global Pharmaceutical Contract Manufacturing Market Segmentation
1.2 Global Pharmaceutical Contract Manufacturing Market Overview
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pharmaceutical Contract Manufacturing
2.1 What is Pharmaceutical Contract Manufacturing?
2.2 The Benefits of Outsourcing in the Pharmaceutical Market
2.3 Pharmaceutical Contract Manufacturing Services
2.4 Strategy and Tactics: The Importance of Outsourcing Wisely
2.5 Trends in Contract Manufacturing, 2016-2026
2.6 Pharmaceutical Contract Manufacturing: Market Segmentation

3. Pharmaceutical Contract Manufacturing: World Market 2015-2026
3.1 Pharmaceutical Contract Manufacturing Market: Historical Performance 2012-2014
3.1.1 Contract Manufacturing is the Most Mature Pharma Outsourcing Sector
3.1.2 The Pharma Contract Manufacturing Market by Sector 2014
3.2 Pharma Contract Manufacturing: Overall Market Forecast 2015-2026
3.2.1 Changing Submarket Shares by Segment 2015-2026
3.2.2 Drivers for Growth in the Contract Manufacturing Market to 2026
3.2.3 Generics: A Driver or Restraint?
3.2.4 Other Contract Manufacturing Services Submarket: Outlook and Forecast 2014-2016
3.2.4.1 Increasing Demand for Formulation Development Services

4. The Contract API Manufacturing Services Submarket 2015-2026
4.1 The Contract API Manufacturing Submarket 2014
4.1.1 Chemical APIs Will Experience Resurgence After the Shift of Focus to Biological APIs
4.1.2 The API Manufacturing Submarket by Sector 2014
4.2 The Contract API Manufacturing Submarket: Outlook and Forecast 2015-2026
4.2.1 Drivers for Growth in the API Submarket to 2026
4.2.2 The Potential for Microreactors in Commercial Manufacturing to 2026
4.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket?
4.2.4 Contract API Manufacturing Submarket Restraint 2016-2026
4.2.4.1 Backwards Integration for Generics Manufacturers
4.3 The Contract Generic API Manufacturing Submarket 2015-2026
4.3.1 The Contract Generic API Manufacturing Submarket Forecast 2015-2026
4.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2026
4.3.2.1 The US Generic Drug User Fee Act and API Manufacturing
4.4 The Contract HPAPI Manufacturing Submarket 2015-2026
4.4.1 Challenges and Opportunities in High Containment Manufacturing
4.4.2 Company Investment into HPAPI Manufacturing Facilities: Growth Increases in the HPAPI Manufacturing Sector
4.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2015-2026
4.4.4 The Contract HPAPI Manufacturing Submarket Drivers and Restraints to 2026

5. The Contract FDF Manufacturing Services Submarket 2015-2026
5.1 The Contract FDF Manufacturing Submarket 2014
5.1.1 Solid Dosage Manufacturing Leads the Market
5.1.2 CMOs Report High Demand for Softgel Formulations
5.2 The Contract FDF Manufacturing Submarket Forecast 2015-2026
5.2.1 Complex Molecule Manufacturing Will Drive Growth to 2026
5.2.2 What Will Restrain Growth in FDF Outsourcing?
5.3 The Contract Solid Dosage Manufacturing Submarket 2015-2026
5.3.1 How Will Revenue for Solid Dosage Manufacturing Grow to 2026?
5.3.2 The Solid Dosage Manufacturing Submarket Drivers and Restraints 2016-2026
5.3.2.1 Will Product Reformulation Drive Growth to 2026?
5.4 The Contract Injectable Dosage Manufacturing Submarket 2015-2026
5.4.1 The Contract Injectable Dosage Manufacturing Submarket Forecast 2015-2026
5.4.1.1 Drug Shortages Offer Opportunity to CMOs in the Short-Term
5.4.2 Demand for Biopharma Manufacturing Will Drive Growth 2016-2026
5.4.2.1 Interest in Antibody-Drug Conjugate Development Is Growing
5.4.2.2 Challenges in Manufacturing Antibody-Drug Conjugates
5.4.3 Lyophilisation and Aseptic Filling Demand Will Rise
5.4.3.1 Will Spray Drying Replace Lyophilisation in FDF Manufacturing?

6. Leading National Markets for Pharmaceutical Contract Manufacturing 2015-2026
6.1 Leading National Markets for Pharmaceutical Contract Manufacturing 2014
6.1.1 Challenges in Assessing the Market: Supply versus Demand
6.1.2 Leading National Pharmaceutical Contract Manufacturing Markets: Revenue Forecasts 2015-2026
6.1.3 Pharmaceutical Manufacturing in the US: Regulatory Oversight 2014
6.1.4 Controlling Foreign Manufacturing Sites
6.1.5 What Impact Will the GDUFA 2012 Have on Foreign Manufacturing?
6.1.6 Outsourcing and US Manufacturing Regulations
6.1.7 Increased Demand for Domestic API Manufacturing?
6.2 The US Contract Manufacturing Market Forecast 2015-2026
6.3 Outlook for Pharmaceutical Contract Manufacturing in the EU
6.3.1 The EU is the Leading Destination for Pharmaceutical Contract Manufacturing
6.3.2 Regulatory Aspects of Pharma Manufacturing in the EU
6.3.2.1 The European Commission Amends Annex 16
6.3.2.2 The Falsified Medicine Directive: Controlling API Imports
6.3.3 Biopharma Manufacturing Demand Will Rise to 2026
6.3.4 The EU Contract Manufacturing Market Forecast 2015-2026
6.3.5 Germany: The Leading EU Destination for API and FDF Manufacturing
6.3.5.1 Demand for Contract Manufacturing in Germany: Revenue Forecast 2015-2026
6.3.6 CMOs Account for a Third of Manufacturing Sites in France
6.3.6.1 French Pharma Contract Manufacturing Market Forecast 2015-2026
6.3.7 Italy: Strong API Manufacturing Traditions
6.3.7.1 Revenue Forecast for the Italian Pharma Contract Manufacturing Market 2015-2026
6.3.8 Spain: How Will Demand for Manufacturing Services Grow to 2026?
6.3.9 UK: Pharmaceutical Contract Manufacturing Market Forecast 2015-2026
6.4 Pharma Contract Manufacturing in Japan to 2026
6.4.1 Pharmaceutical Manufacturing Regulations in Japan
6.4.1.1 The Pharmaceutical Affairs Law
6.4.2 Greater API Outsourcing to Drive Japanese Market Growth to 2026 In Spite of Currency Devaluation Weakening the Economy

7. Leading Emerging Markets for Pharmaceutical Contract Manufacturing 2015-2026
7.1 Pharmaceutical Contract Manufacturing in Developing Countries
7.1.1 Outsourcing to Emerging National Markets from Developed Markets
7.1.1.1 Demand Will Increase for Services in India and China
7.1.2 Domestic Demand for Pharmaceutical Contract Manufacturing Services
7.1.3 Pharmaceutical Contract Manufacturing: Leading Emerging National Market Forecasts 2015-2026
7.2 Chinese Demand for Pharma Contract Manufacturing Services 2015-2026
7.2.1 Improved Manufacturing Regulations in China
7.2.1.1 New Regulations for Excipients and Guidance for API Manufacturing 2012-2013
7.2.1.2 What Are the Consequences to Stricter Manufacturing Regulations in China?
7.2.2 Chinese CMOs Are Investing in Biopharma Manufacturing
7.2.3 China Pharma Contract Manufacturing Market Forecast 2015-2026
7.3 India: CMOs with Strong Infrastructure and Growing Expertise
7.3.1 Regulatory Outlook for Indian Pharma Manufacturing
7.3.1.1 Stricter Quality Standards to Ensure Compliance with EU Rules
7.3.2 Domestic Manufacturing Dominates the Indian Pharma Market
7.3.3 Demand for Contract Manufacturing in India: Market Forecast 2015-2026
7.4 Brazil: Contract Manufacturing Outlook 2015-2026
7.4.1 Pharmaceutical Manufacturing Regulations in Brazil
7.4.1.1 New Guidelines and Regulations Proposed 2012-2013
7.4.2 Brazil Imports Most of its APIs
7.4.3 Brazil: Pharma Contract Manufacturing Market Forecast 2015-2026
7.5 The Russian Pharma Contract Manufacturing Market 2015-2026
7.5.1 Pharma Manufacturing Regulations in Russia
7.5.1.1 Compliance with GMP in Russia
7.5.2 How Will Demand for Contract Manufacturing Grow in Russia to 2026?
7.6 South Korea: Government Supported Growth
7.6.1 South Korea: Strict GMP Regulations
7.6.2 South Korea: Pharma Contract Manufacturing Market Forecast 2015-2026

8. Leading Companies in the Pharmaceutical Contract Manufacturing Market
8.1 Leading CMOs in the Pharmaceutical Contract Manufacturing Market
8.2 Catalent: Leading CMO
8.2.1 Multiple Expansions and Increased Focus on Biologic Manufacturing
8.3 Lonza: Potential to Lead in ADC Manufacturing
8.3.1 Lonza: Expanding its Capacities to Meet Customer Demand for Biologic Manufacturing
8.4 Evonik Degussa: Specialising in Small Molecules
8.4.1 Developments at Evonik Degussa
8.5 DPx Holdings – DSM and Patheon: Recent Merger Has Strengthened Their Position
8.5.1 Increasing Capacity Tactically and Expanding Worldwide
8.6 Teva: The World’s Largest API Manufacturer
8.6.1 Will Teva Expand into Emerging Markets?
8.7 Boehringer Ingelheim BioXcellence: Boehringer’s Biopharma Manufacturing Division
8.7.1 Adding New Services for Growth
8.8 Famar: A Possible Candidate for Acquisition
8.9 Fareva: A Strategic Shift from Acquisition to Increase in Capacity
8.10 Vetter Pharma: Specialists in Aseptic Filling, Lyophilisation and Siliconisation
8.10.1 Vetter’s Growth: Increasing in Capacity and Market Expansion
8.11 Mylan: A World Leader in Generics Manufacturing

9. Pharmaceutical Contract Manufacturing Industry Trends: Qualitative Analysis from a CMO Perspective 2016-2026
9.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a CMO Perspective 2016-2026
9.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a CMO Perspective 2016-2026
9.3 Pharma Contract Manufacturing Market: STEP Analysis 2016-2026
9.3.1 Social Factors
9.3.2 New Technologies Will Drive Market Growth to 2026
9.3.2.1 Advantages of Single-Use Technologies in Biopharma Manufacturing
9.3.2.2 Green Technology in Contract Manufacturing
9.3.2.3 Drug Delivery Trends and CMOs
9.3.2.4 Biologics Are Causing Increased Demand for Lyophilisation
9.3.2.5 Improving Solubility and Stability for Small Molecules
9.3.2.6 Spray Drying as an Advantageous Alternative to Lyophilisation
9.3.2.7 Hot-Melt Extrusion: A Niche Opportunity
9.3.3 Economic Pressures
9.3.3.1 Developed-Market CMOs Facing Competition from Emerging Markets
9.3.4 Political Issues
9.3.4.1 How Will Regulatory Developments Affect CMOs?
9.4 Trends in Drug Development Affecting CMOs to 2026
9.4.1 Orphan Drug Development: Smaller Manufacturing Capacities
9.4.2 Complex Biologics: Interest in ADCs is Increasing
9.4.3 How Will Biosimilar Market Growth Affect CMOs?
9.4.4 The Future of Small Molecule Outsourcing
9.5 How Will CMOs Expand in the Coming 10 Years?
9.5.1 CMO Consolidation Will Increase
9.5.2 There Will Be More Manufacturing Facilities Available for Acquisition
9.6 Developments in the Manufacturing Process 2016-2026
9.6.1 Rising Interest from Companies in Quality by Design (QbD)
9.6.2 A Move Towards Continuous Manufacturing

10. Pharmaceutical Contract Manufacturing Trends: Qualitative Analysis of the Pharmaceutical Contract Manufacturing Market from a Client Perspective 2016-2026
10.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses from a Client Perspective 2016-2026
10.2 Pharma Contract Manufacturing Market: Opportunities and Threats from a Client Perspective 2016-2026
10.3 Important Aspects of the Outsourcing Decision
10.3.1 What Factors Will Influence CMO Selection?
10.3.2 CMO-Pharma Partnering Models
10.3.3 Strategic Partnering
10.3.4 Selecting a Local CMO vs. Offshoring
10.3.5 CMOs in Emerging Markets
10.3.6 Good Communication is Vital for Success
10.3.7 Ensuring Protection in Intellectual Property and Tech Transfer
10.3.8 Regulatory Compliance is a Key Deciding Factor for Pharma Clients
10.3.8.1 Regulatory Bodies and Outsourcing
10.3.8.2 Quality Agreement
10.3.8.3 Global Harmonisation Will Improve Compliance
10.4 Trends in Outsourcing Partnerships 2016-2026
10.4.1 Big Pharma and Outsourced Manufacturing
10.4.2 Small and Virtual Pharma Companies
10.4.3 How Will Biotech Funding Impact the Pharma Contract Manufacturing Industry to 2026?

11. Research Interviews
11.1 Interview with Gordon Bates, SVP Business Unit Head, Chemical and Microbial Manufacturing, Lonza Pharma & Biotech
11.1.1 Lonza’s Pharmaceutical Contract Manufacturing Capabilities and Experience
11.1.2 Upcoming Trends in Drug Development that Will Affect the Pharmaceutical Contract Manufacturing Industry
11.1.3 The Potential of the Emerging Marketplace
11.1.4 Outlook on Qualities Needed For CMO Success
11.1.5 Industry Trends: Changes in the Next Ten Years
11.2 Interview with Dr Michael Quirmbach, VP, Global Sales and Marketing, CordenPharma International
11.2.1 The Range of CDMO Services Available at CordenPharma
11.2.2 CordenPharma’s Systematic Approach Navigates the Challenges of HPAPI Manufacturing
11.2.3 Future Trends in the Developed and Emerging Markets for Contract Manufacturing
11.2.4 Certain Manufacturing Sectors are Primed for Growth While Others Decline
11.2.5 Factors for CDMO Success in the Contract Manufacturing Market

12. Conclusions
12.1 The World Pharmaceutical Contract Manufacturing Market
12.2 Outlook for the Market to 2026
12.2.1 Rising Demand for High Value Services 2016-2026
12.2.2 Demand Will Be Highest Among Developed-Market Clients
12.3 Which New Technologies Will Stimulate Demand to 2026?


【レポート販売概要】

■ タイトル:医薬品製造委託の世界市場2016-2026
■ 英文:Pharmaceutical Contract Manufacturing Market 2016-2026 : Discover Revenue Forecasts for Active Ingredient (API) and Finished Dose Formulation (FDF) Services
■ 発行日:2016年3月
■ 調査会社:visiongain
■ 商品コード:VGAIN6041532
■ 調査対象地域:グローバル
  • 半導体用加熱蒸着装置の世界市場
    ABSTRACTAbout Semiconductor Thermal Evaporator Semiconductor evaporation is a process that involves depositing a thin layer of material on a wafer or the surface of a substrate. A thermal evaporator is used to deposit material on the substrate. It is one of the simplest methods to attain thin film deposition. It uses an electric resistance heater to melt the material. The vapor that is created is …
  • 世界の核酸検査/NAT市場
    This unique report from VPGMarketResearch provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies …
  • Menjugate (Meningococcal Vaccines):市場予測と分析(~2022)
    Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines. Menjugate (Meningococcal …
  • 軽自動車の北米市場予測(~2021)
    The light duty vehicle market for North America is projected to grow at a CAGR of 5.65% during the forecast period, to reach 24540.0 thousand units by 2021, from an estimated 18647.1 thousand units in 2016. The base year for the report is 2015 and the forecast year is 2021. The increasing demand for light duty vehicles in North America, stringent emission regulations leading to light weighting/eng …
  • 不織フィルタ媒体の世界市場分析:技術別(スパンボンド、メルトブローン、ウェットレイド、ニードルパンチ)、用途別(輸送、水ろ過、HVAC、食品・飲料、医療、製造、先端技術、炭化水素処理)、セグメント予測
    The global nonwoven filter market is expected to reach USD 8.32 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand for filtration in industries such as healthcare, transportation, food & beverages, and various others is expected to benefit the global nonwoven filter media market. Global agencies such as UN have issued directives and prescriptions to keep air …
  • Lundin Petroleum AB:石油・ガスバリューチェーン分析レポート2013
    Lundin Petroleum AB Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Lundin Petroleum AB" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Lundin Petroleum AB”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
  • 成形パルプ包装の世界市場予測(~2024年)
    “Growth in demand from the food packaging industry to drive the market for molded pulp packaging” The global market for molded pulp packaging is projected to grow from USD 3.5 billion in 2019, to reach USD 4.4 billion by 2024, at a CAGR of 4.4%. The molded pulp packaging market is driven by factors such as the growing demand for sustainable packaging, increase in demand for recyclable packaging pr …
  • 世界のスマートグラス市場:用途別、技術別分析
    About Smart Glass A smart glass or switchable glass is a unique type of glass, and it can change its light transmission properties. Based on the types of external stimuli needed for a change, smart glass can be bifurcated into two types: active and passive. In the case of passive glass, heat and ultraviolet light sources are used to initiate the change, whereas electrical current acts as the stimu …
  • フォトニックセンサの世界市場:光ファイバーセンサ、バイオフォトニックセンサ、イメージセンサ
    About Photonic Sensor The use of light as an instrument of precision creates numerous opportunities for sensing technology and analytics. Photonic sensors are devices that have the capability to sense light and release electrical pulses. Since their introduction, the devices have evolved continuously and are being used in several industries. The use of photonic sensing technology has the following …
  • Crowley Maritime Corporation:石油・ガスバリューチェーン分析レポート2013
    Crowley Maritime Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Crowley Maritime Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Crowley Maritime Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the valu …
  • 電気・電子産業におけるDM(デジタルマニュファクチャリング)の世界市場2017-2021
    About Digital Manufacturing DM is one of the emerging PLM solutions in the world. The adoption of DM allows the engineers to create a virtual environment of the manufacturing process starting from product definition to manufacturing. It creates digital models of tools, assembly lines, work centers, plant layout, and resources. DM provides simulation, visualization, analytics, and collaboration to …
  • アメリカの抗凝固剤市場2016-2020
    About the Anti-Coagulant Drugs Market Anticoagulants have been used for over 80 years to treat clotting disorders. It is used as a first line of defense for disorders such as deep vein thrombosis (DVT), pulmonary embolism, AF, and acute coronary syndrome. With the advent of time, traditional therapies are replaced by novel oral anticoagulants, which have better safety and efficacy profiles. The 19 …
  • 輸血診断検査のグローバル市場動向2014
    This report provides a worldwide overview of the transfusion testing market, including estimates of facilities performing transfusion testing tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.Contains 15 pages and 5 tables
  • 高性能熱可塑性樹脂の世界市場:特殊ナイロン、PPS、スルホンポリマー、液晶ポリマー、芳香族ポリケトン、ポリエーテルイミド
    About High-performance Thermoplastics High-performance thermoplastics are highly specific polymers that find application in highly specialized applications across various sectors and industries. They are highly priced, sold in low volumes, and have a combination of extraordinary properties such as superior temperature tolerance, chemical, flame, and radiation resistance, improved mechanical proper …
  • 汗腺膿瘍:グローバル臨床試験レビューH1, 2014
    Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014" provides data on the Hidradenitis Suppurativa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hidradenitis Suppurativa. It includes an overview of the trial num …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。